Peter P. Toth, MD, PhD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Eli Lilly and Company(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT) SPEAKER'S BUREAU: Amgen(SIGNIFICANT), Novo-Nordisk(SIGNIFICANT)

View Full Disclosure